The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
Today I'll be reading one of my recent newsletters! It's kind of a fun run-down of my anti-azathioprine stance. As I say in the piece, some patients may benefit from azathioprine and I am not saying it is an entirely useless drug or that nobody should ever prescribe it. Rather, I am just saying that it is likely the worst option for nearly every indication for which it could be prescribed.
Please subscribe AND JOIN my newsletter if you would like to support my writing and podcasting! https://t.co/RIzRvWnSfv
E71: MTX Discontinuation Post... Influenza Vaccination
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
E69: Publication Trends in SRMAs and RCTs
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
E67: Belimumab in Lupus Nephritis (BLISS-LN)
E66: MRI to Diagnose PMR
E65: Anifrolumab in SLE - A Reply
E63: Housekeeping #3
E57: PEXIVAS Trial - PLEX and Reduced Steroid in ANCA Vasculitis
E56: Continue or Withdraw Prednisone in SLE (CORTICOLUP)
E55: Anifrolumab for SLE (TULIP 1&2)
E54: Rheum4Debate - Triple Tx is 1st Line in RA w/No Response to MTX
E53: Another Look at Nintedanib for SSc-ILD
E52: HOPE RCT - Prednisone for OA of the Hand
E51: Rheum4Debate - "Start TCZ Upfront in GCA"
E50: Housekeeping 2
E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
E47: HCQ Blood Levels and HCQ Retinopathy
E46: Rituximab in Lupus
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive